A Four-Gene Promoter Methylation Marker Panel Consisting of <i>GREM1, NEURL, LAD1,</i> and <i>NEFH</i> Predicts Survival of Clear Cell Renal Cell Cancer Patients.-论文-万方医学网

第一作者： Iris J H,van Vlodrop

第一单位： Department of Pathology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.

作者： Iris J H,van Vlodrop ^[1] ; Sophie C,Joosten ^[2] ; Tim,De Meyer ^[3] ; Kim M,Smits ^[1] ; Leander,Van Neste ^[4] ; Veerle,Melotte ^[1] ; Marcella M L L,Baldewijns ^[1] ; Leo J,Schouten ^[1] ; Piet A,van den Brandt ^[5] ; Jana,Jeschke ^[5] ; Joo Mi,Yi ^[6] ; Kornel E,Schuebel ^[7] ; Nita,Ahuja ^[8] ; James G,Herman ^[6] ; Maureen J,Aarts ^[6] ; Fred T,Bosman ^[9] ; Wim,Van Criekinge ^[2] ; Manon,van Engeland ^[1]

作者单位： Department of Pathology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. ^[1] Division of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. ^[2] BioBix: Laboratory of Bioinformatics and Computational Genomics, Department of Mathematical Modeling, Statistics and Bioinformatics, Ghent University, Ghent, Belgium. ^[3] Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. ^[4] Department of Epidemiology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. ^[5] The Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins University School of Medicine, Baltimore, Maryland. ^[6] Laboratory of Cancer Epigenetics, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium. ^[7] Research Institute, Dongnam Institute of Radiological and Medical Sciences (DIRAMS), Jangan-eup, Gijang-gun, Busan, Korea. ^[8] Hillman Cancer Center, Pittsburgh, Pennsylvania. ^[9] Department of Pathology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. manon.van.engeland@mumc.nl. ^[10]

主题词成年人(Adult);老年人(Aged);自身抗原(Autoantigens);癌, 肾细胞(Carcinoma, Renal Cell);DNA甲基化(DNA Methylation);无病生存(Disease-Free Survival);女(雌)性(Female);高通量核苷酸序列分析(High-Throughput Nucleotide Sequencing);人类(Humans);胞间信号肽类和蛋白质类(Intercellular Signaling Peptides and Proteins);Kaplan-Meiers评估(Kaplan-Meier Estimate);肾肿瘤(Kidney Neoplasms);男(雄)性(Male);中年人(Middle Aged);神经微丝蛋白质类(Neurofilament Proteins);非纤维状胶原(Non-Fibrillar Collagens);寡核苷酸序列分析(Oligonucleotide Array Sequence Analysis);预后(Prognosis);启动区, 遗传(Promoter Regions, Genetic);比例危险度模型(Proportional Hazards Models);泛素蛋白连接酶类(Ubiquitin-Protein Ligases)

DOI 10.1158/1078-0432.CCR-16-1236

PMID 27756787

发布时间 2023-12-13

检索历史清除

A Four-Gene Promoter Methylation Marker Panel Consisting of <i>GREM1, NEURL, LAD1,</i> and <i>NEFH</i> Predicts Survival of Clear Cell Renal Cell Cancer Patients.

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Four-Gene Promoter Methylation Marker Panel Consisting of <i>GREM1, NEURL, LAD1,</i> and <i>NEFH</i> Predicts Survival of Clear Cell Renal Cell Cancer Patients.

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

检索历史清除